这篇报导描述 Andrew Gallimore 推动的延长式 DMT（DMTx）计划：以靶控静脉输注延长高峰状态，将常见吸入 DMT 的 10 至 15 分钟高峰，扩展到约 30 分钟。2022 年 Imperial College London 的首个 DMTx 临床研究仅有 11 名受试者。新机构 Eleusis 将于 3 月 18 日在 Bequia 启动，定位为心智版 SETI，目标是与体验中所见的非人实体建立可持续双向互动。

Eleusis 同时结合研究与疗程，预计本月接待 30 名访客；其方案起价为 9,500 美元，内容含 96 小时（4 天）行程、2 次 DMTx、住宿与餐食。团队主张可依耐受度即时上调或下调剂量，必要时中止输注，效果可在数分钟内消退，作为相较 ayahuasca 约 360 分钟（6 小时）高压历程的可控替代。文章亦引用研究称，约 94% 的 DMT 旅程涉及实体遭遇感。

核心争点在诠释：Gallimore 认为这些实体可能对应独立于人类感官之外的真实层域；Robin Carhart-Harris 与 Susan Blackmore 则倾向其为高熵脑状态下的社会知觉投射。方法学上，Noonautics 提议跨学科进入同一状态，结合数学与语言测试检验其智能主张，但可重复性、实体合作度与意识测量仍是主要限制。临床上，若此经验能打破心理僵局，其治疗价值未必取决于实体是否客观存在。

The article profiles Andrew Gallimore’s extended DMT program, DMTx, which uses target-controlled intravenous infusion to lengthen peak states: typical inhaled DMT peaks of 10 to 15 minutes are extended to about 30 minutes. The first DMTx clinical study at Imperial College London in 2022 enrolled only 11 volunteers. A new center, Eleusis, launches on March 18 in Bequia as a mind-SETI project aiming for sustained two-way interaction with perceived nonhuman entities.

Eleusis combines research and retreat care, expects 30 guests this month, and markets a package starting at $9,500 that includes 96 hours (4 days), two DMTx sessions, lodging, and food. Operators argue dosing can be titrated up or down in real time and stopped if needed, with effects fading within minutes, as a controllable alternative to ayahuasca’s roughly 360-minute (6-hour) ordeal. The report also cites a study estimating entity encounters in around 94 percent of DMT trips.

The central dispute is interpretive: Gallimore argues these entities may indicate access to a reality independent of ordinary human sensing, while Robin Carhart-Harris and Susan Blackmore frame them as socially primed perceptual constructions emerging from high-entropy brain states. Methodologically, Noonautics proposes multidisciplinary entrants plus mathematical and linguistic probes to test intelligence claims, but replication, entity cooperation, and consciousness measurement remain major constraints. Clinically, if the experience breaks psychological ruts, therapeutic value may not depend on whether entities are objectively real.